Context Therapeutics (CNTX) Prepaid Assets (2020 - 2026)

Context Therapeutics' (CNTX) quarterly Prepaid Assets came in at $4.0 million in Q1 2026, up 18.04% year-on-year from $3.4 million in Q1 2025, and up 69.1% quarter-over-quarter from $2.4 million in Q4 2025.

Context Therapeutics (CNTX) Prepaid Assets (2020 - 2026) Analysis & Trends

Context Therapeutics has disclosed Prepaid Assets across 7 years of filings, most recently posting $4.0 million for Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $4.0 million, up 18.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (up 18.04% YoY), and the FY2025 annual result was $2.4 million, down 31.96% from the prior year.
  • Prepaid Assets came in at $4.0 million for Q1 2026 at Context Therapeutics, up from $2.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.0 million in Q1 2026 to a low of $949489.0 in Q1 2024.
  • The 5-year median for Prepaid Assets is $2.1 million (2025), against an average of $2.2 million.
  • Across the five-year window, Prepaid Assets jumped 13568.19% in 2022 and slumped 55.14% in 2024, its largest moves.
  • Context Therapeutics' Prepaid Assets stood at $2.4 million in 2022, then tumbled by 32.21% to $1.6 million in 2023, then soared by 116.99% to $3.5 million in 2024, then tumbled by 31.96% to $2.4 million in 2025, then surged by 69.1% to $4.0 million in 2026.
  • The last three Prepaid Assets figures came in at $4.0 million (Q1 2026), $2.4 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Context Therapeutics 166.57 Mn 166.57 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.99 Mn
Dec 31, 2025 2.36 Mn
Sep 30, 2025 2.12 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 3.38 Mn
Dec 31, 2024 3.47 Mn
Sep 30, 2024 1.27 Mn
Jun 30, 2024 1.16 Mn
Mar 31, 2024 949,489.00
Dec 31, 2023 1.60 Mn
Sep 30, 2023 1.29 Mn
Jun 30, 2023 2.57 Mn
Mar 31, 2023 2.12 Mn
Dec 31, 2022 2.36 Mn
Sep 30, 2022 2.51 Mn
Jun 30, 2022 1.58 Mn
Mar 31, 2022 1.13 Mn
Dec 31, 2021 1.62 Mn
Sep 30, 2021 18,379.00
Dec 31, 2020 8,672.00